Laith Khalil
Family Medicine · Adrian, MINPI 1518589894
Payments from drug & device makers
Across 134 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$333
- Novo Nordisk$263
- AbbVie$227
- Otsuka America Pharmaceutical, Inc.$204
- Pfizer$199
- Bayer$169
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $333 |
| Novo Nordisk | 14 | $263 |
| AbbVie | 12 | $227 |
| Otsuka America Pharmaceutical, Inc. | 10 | $204 |
| Pfizer | 10 | $199 |
| Bayer | 2 | $169 |
| Braeburn Inc. | 7 | $148 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $141 |
| Lundbeck LLC | 7 | $138 |
| AstraZeneca | 7 | $121 |
| Indivior Inc. | 6 | $115 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Exact Sciences | 6 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| GSK | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Amgen | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Corcept Therapeutics | 2 | $35 |
| USWM, LLC | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $28 |
| Viatris Specialty LLC | 1 | $23 |
| Tempus AI, Inc | 1 | $19 |
| Medtronic | 1 | $16 |
| Abiomed | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$150
How this compares
$2,730 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 87 | $75,428 |
| MounjaroTirzepatide | 40 | $48,626 |
| TrulicityDulaglutide | 38 | $37,416 |
| OzempicSemaglutide | 36 | $35,697 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $29,638 |
| SublocadeBuprenorphine | 15 | $29,052 |
| FarxigaDapagliflozin Propanediol | 29 | $28,588 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $21,656 |
| RybelsusSemaglutide | 16 | $17,319 |
| JanuviaSitagliptin Phosphate | 13 | $15,438 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $15,036 |
| MyrbetriqMirabegron | 12 | $6,163 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,258 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $4,189 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 68 | $2,875 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $333 | $86,04278 claims |
| Novo NordiskOzempic, Rybelsus | $263 | $53,01652 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $121 | $43,62447 claims |
| Indivior Inc.Sublocade | $115 | $29,05215 claims |
| GSKTrelegy Ellipta | $66 | $21,65629 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Adrian
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.